Evaluation of stability of live attenuated camelpox vaccine stabilized with different stabilizers and reconstituted with various diluents

Leese, 1909, Two diseases of young camels, J Trop Vet Sci, 4, 1 Bhanuprakash, 2010, Camelpox: epidemiology, diagnosis and control measures, Expert Rev Anti Infect Ther, 8, 1187, 10.1586/eri.10.105 ICTV, 2005, 123 Afonso, 2002, The genome of camelpox virus, Virology, 295, 1, 10.1006/viro.2001.1343 Al-Ziabi, 2007, The first outbreak of camelpox in Syria, J Vet Med Sci, 69, 541, 10.1292/jvms.69.541 Jezek, 1983, Camelpox and its risk to the human population, J Hyg Epidemiol Microbiol Immunol, 27, 29 Bera, 2011, Zoonotic cases of camelpox infection in India, Vet Microbiol, 152, 29, 10.1016/j.vetmic.2011.04.010 OIE Manual, 2008, vol. 2, 1 Wernery, 2002, Camel pox, 176 Krupenko SS. Camelpox caused by vaccinia virus. Veterinariya, Moscow, No.8, 61-62 (Ru). Cited in The Veterinary Bulletin, 1973; 43(1): 12. Higgins, 1986, 168 Buchnev, 1987, Infectious diseases of camels in the USSR, Rev Sci Tech, 6, 487, 10.20506/rst.6.2.297 Hafez, 1992, Development of a live cell culture camelpox vaccine, Vaccine, 8, 533, 10.1016/0264-410X(92)90353-L Kaaden, 1992, Progress in the development of a camelpox vaccine, 47 Klopries, 1993 Kaaden, 1995, Camel fibroblast cell line Dubca and its use for diagnosis and prophylaxis of camel diseases, A49 Wernery, 1999, Experimental camel pox infection in vaccinated and unvaccinated dromedaries, J Vet Med [B] Infect Dis, 46, 131 WHO, 2009, Guidelines on stability evaluation of vaccines, Biologicals, 37, 424, 10.1016/j.biologicals.2009.08.017 WHO, 2004, Guidelines for clinical evaluation of vaccines: regulatory expectations WHO, 2005, Guidelines for nonclinical evaluation of vaccines Levin, 2007, An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh, Vaccine, 25, 6945, 10.1016/j.vaccine.2007.06.065 Chen, 2009, Opportunities and challenges of developing thermostable vaccines, Expert Rev Vaccines, 8, 547, 10.1586/erv.09.20 Mariner, 1990, Comparison of the effect of various chemical stabilizers and lyophilisation cycles on the thermo-stability of Vero cell-adapted rinderpest vaccine, Vet Microbiol, 21, 195, 10.1016/0378-1135(90)90032-Q Adebayo, 1998, Stability of 17D Yellow fever virus vaccine using different stabilizers, Biologicals, 26, 309, 10.1006/biol.1998.0157 Reed, 1938, A simple method of estimating fifty percent end point, Am J Hyg, 27, 493 Worrall, 2001, Xerovac: an ultra rapid method for the dehydration and preservation of live attenuated rinderpest and peste des petits ruminants vaccines, Vaccine, 19, 834, 10.1016/S0264-410X(00)00229-2 Sarkar, 2003, Comparative efficacy of various chemical stabilizers on the thermo stability of a live-attenuated peste des petits ruminants (PPR) vaccine, Vaccine, 21, 4728, 10.1016/S0264-410X(03)00512-7 Davies, 1975, Characteristics of a Kenyan camelpox virus, J Hyg, 7, 381, 10.1017/S002217240002444X Burke, 1999, Formulation, stability and delivery of live attenuated vaccines for human use, Crit Rev Ther Drug Carr Syst, 16, 1 Precausta, 1982, Modalités de production et immunité conférée par un vaccin antirabique inactivé provenant de culture cellulaire, Comp Immunol Microbiol Infect Dis, 5, 217, 10.1016/0147-9571(82)90041-8 Riyesh, 2011, Evaluation of efficacy of stabilizers on the thermostability of live attenuated thermo-adapted Peste des petits ruminants vaccines, Virol Sin, 26, 324, 10.1007/s12250-011-3205-x Plowright, 1971, Studies on rinderpest culture vaccine IV. The stability of the reconstituted vaccine, Res Vet Sci, 3, 172, 10.1016/S0034-5288(18)34916-6 Anon, 1996, Peste des petits ruminants, 77 Bara, 1989, A qualitative theory of the screening-dinding effects of magnesium salts on epithelial cell membranes: a new hypothesis, Magnes Res, 2, 243